BMS-986251 Catalog No.:M33163-C V2-vasopressin and angiotensin-II type-1 receptors

V2-vasopressin and angiotensin-II type-1 receptors

InChi: InChI=1S/C78H134F4N4O35/c1-93-14-15-97-22-23-101-28-29-103-32-33-105-36-37-107-40-41-109-44-45-111-48-49-113-52-53-115-56-57-117-60-61-119-64-65-120-63-62-118-59-58-116-55-54-114-51-50-112-47-46-110-43-42-108-39-38-106-35-34-104-31-30-102-27-26-100-21-18-96-13-9-84-78(92)69(2-5-74(91)121-77-75(81)67(79)66-68(80)76(77)82)85-71(88)7-11-94-16-19-98-24-25-99-20-17-95-12-8-83-70(87)6-10-86-72(89)3-4-73(86)90/h3-4

preliminary experiments are done to determine the lowest dose for in vivo therapeutic efficacy

Dalosirvat is a topical Wnt pathway activator for the treatment of androgenetic alopecia (AGA)

Thalidomide-C2-amido-C2-COOH can be used to design PROTAC CDK2/9 Degrader-1 (HY-130709)

BMS-986251 Catalog No.:M33163-C V2-vasopressin and angiotensin-II type-1 receptorsBMS 986251 is an orally active and selective RORt inverse agonist with an EC50 of 12 nM for RORt GAL4. BMS 986251 inhibits IL 17 with an EC50 of 24 nM in human whole blood assay. BMS 986251 demonstrates robust efficacy in mouse acanthosis and Imiquimod induced (HY B0180) models (preclinical models of psoriasis). Product information CAS Number: 2460133 35 9 Molecular Weight: 667. 61 Formula: C30H29F8NO5S Chemical Name: (1R,3S,4R) 4 [(3aR,9bR) 9b (4